Widespread vascular production of C-reactive protein (CRP) and a relationship between serum CRP, plaque CRP and intimal hypertrophy

Atherosclerosis

Volumn 191, Issue 1, 2007, Pages 175-181

  Wilson, A M ^a   Swan, J D ^a   Ding, H ^c   Zhang, Y ^a   Whitbourn, R J ^a   Gurry, J ^b   Yii, M ^b   Wilson, A C ^b   Hill, M ^c   Triggle, C ^c   Best, J D ^a   Jenkins, A J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c RMIT UNIVERSITY   (Australia)

Author keywords

Atherosclerosis; C reactive protein; Diabetes; Inflammation; Intimal hypertrophy

Indexed keywords

C REACTIVE PROTEIN; MESSENGER RNA;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY SINUS; FEMALE; HEART ATRIUM; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CAROTID STENOSIS; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; CROSS-SECTIONAL STUDIES; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SAPHENOUS VEIN; TUNICA INTIMA;

EID: 33846862465     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.03.034     Document Type: Article

References (29)

1. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
2. Bermudez E.A., Rifai N., Buring J., Manson J.E., and Ridker P.M. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 22 (2002) 1668-1673
3. Hulthe J., Wikstrand J., Mattsson-Hulten L., and Fagerberg B. Circulating ICAM-1 (intercellular cell-adhesion molecule 1) is associated with early stages of atherosclerosis development and with inflammatory cytokines in healthy 58-year-old men: the Atherosclerosis and Insulin Resistance (AIR) study. Clin Sci (Lond) 103 (2002) 123-129
4. Pepys M.B., and Baltz M.L. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 34 (1983) 141-212
5. Calabro P., Willerson J.T., and Yeh E.T. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108 (2003) 1930-1932
6. Yasojima K., Schwab C., McGeer E.G., and McGeer P.L. Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 158 (2001) 1039-1051
7. Ouchi N., Kihara S., Funahashi T., et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107 (2003) 671-674
8. Pepys M.B., and Hirschfield G.M. C-reactive protein: a critical update. J Clin Invest 111 (2003) 1805-1812
9. Chang M.K., Binder C.J., Torzewski M., and Witztum J.L. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci USA 99 (2002) 13043-13048
10. Stein M.P., Edberg J.C., Kimberly R.P., et al. C-reactive protein binding to FcgammaRIIa on human monocytes and neutrophils is allele-specific. J Clin Invest 105 (2000) 369-376
11. Taskinen S., Kovanen P.T., Jarva H., Meri S., and Pentikainen M.O. Binding of C-reactive protein to modified low-density-lipoprotein particles: identification of cholesterol as a novel ligand for C-reactive protein. Biochem J 367 (2002) 403-412
12. Pepys M.B. C-reactive protein fifty years on. Lancet 1 (1981) 653-657
13. Torzewski J., Torzewski M., Bowyer D.E., et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 18 (1998) 1386-1392
14. Torzewski M., Rist C., Mortensen R.F., et al. C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 20 (2000) 2094-2099
15. Pasceri V., Willerson J.T., and Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102 (2000) 2165-2168
16. Verma S., Wang C.H., Li S.H., et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106 (2002) 913-919
17. Ishikawa T., Imamura T., Hatakeyama K., et al. Possible contribution of C-reactive protein within coronary plaque to increasing its own plasma levels across coronary circulation*1. Am J Cardiol 93 (2004) 611-614
18. Shah P.K. Inflammation, neointimal hyperplasia, and restenosis: as the leukocytes roll, the arteries thicken. Circulation 107 (2003) 2175-2177
19. Wang C.H., Li S.H., Weisel R.D., et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 107 (2003) 1783-1790
20. Rahel B.M., Visseren F.L., Suttorp M.J., et al. Preprocedural serum levels of acute-phase reactants and prognosis after percutaneous coronary intervention. Cardiovasc Res 60 (2003) 136-140
21. Segev A., Kassam S., Buller C.E., et al. Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting. Eur Heart J 25 (2004) 1029-1035
22. Kobayashi S., Inoue N., Ohashi Y., et al. Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein. Arterioscler Thromb Vasc Biol 23 (2003) 1398-1404
23. Paul A., Ko K.W., Li L., et al. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation 109 (2004) 647-655
24. Aviles R.J., Martin D.O., Apperson-Hansen C., et al. Inflammation as a risk factor for atrial fibrillation. Circulation 108 (2003) 3006-3010
25. Mevorach D. Opsonization of apoptotic cells. Implications for uptake and autoimmunity. Ann NY Acad Sci 926 (2000) 226-235
26. Takeda T., Hoshida S., Nishino M., et al. Relationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive C-reactive protein levels. Atherosclerosis 169 (2003) 155-158
27. Jenkins D.J., Kendall C.W., Marchie A., et al. Effects of a dietary portfolio of cholesterol-lowering foods vs. lovastatin on serum lipids and C-reactive protein. JAMA 290 (2003) 502-510
28. Valsamakis G., McTernan P.G., Chetty R., et al. Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. Metabolism 53 (2004) 430-434
29. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511